Overview For the past 33 years, the Michigan Diabetes Research and Training Center (MDRTC) Pilot/Feasibility Study (P/FS) Grants Program has attracted young investigators to diabetes-related research and has stimulated new biomedical, behavioral, clinical, epidemiologic, translational, and health services research. On rare occasions, P/FS grants have also encouraged established investigators in other disease areas to focus their expertise on problems related to diabetes, and established investigators in diabetes to explore new, high-risk directions. Major benefits of the P/FS Grants Program are that it has attracted new investigators into research careers in diabetes and related disorders, has attracted investigators from Schools and Institutes across the University of Michigan (UM) to participate in the MDRTC, and has made the MDRTC a catalyst for new interdisciplinary collaborations. With establishment of the Michigan Center for Diabetes Translational Research (MCDTR), we propose to expand the P/FS Grants Program to type 2 translational researchers who are center members across the region and nation, to further stimulate new investigators to enter the field and to foster productive collaborations. The ultimate goal of the P/FS grants program is to enable awardees to generate sufficient bodies of preliminary data to successfully apply for major research funding from the NIH or other national granting agencies and to accelerate the pace of translation of proven-effective interventions into real world health care settings, communities, and populations at risk. Each year, $50,000 in NIH funds awarded to the MCDTR will be devoted to funding at least two P/FS grants. NIH funds may be supplemented with institutional funds (see below). Management The Administration Core of the MCDTR will oversee the P/FS Grants Program. In order to optimize the use of NIH funds, the MCDTR and the MDRTC will share responsibility for the administration of the P/FS Grants Program. William H. Herman, M.D., M.P.H. and Martin G. Myers, Jr., M.D., Ph.D. will co-direct the program. Together they will solicit applications and requests for extramural peer review, assign internal reviewers, convene the meeting of the P/FS Grants Program Advisory Council, notify awardees, and track outcomes including subsequent extramural grant awards and publications. After the award, the Administration Core will also ensure distribution of funds to awardees, monitor expenditures, and obtain annual status reports on funded projects. Dr. Herman provides scientific oversight for the identification of external reviewers for T1 and T2 translational research applications and Dr. Myers provides oversight for the biomedical research applications. Currently, the Grants Program Advisory Council includes 7 translational researchers and 7 biomedical researchers (Table 1). In the future, a minimum of one-third of Council members will be experts in type 2 translational research in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK092926-02
Application #
8382567
Study Section
Special Emphasis Panel (ZDK1-GRB-1)
Project Start
Project End
2016-08-31
Budget Start
2012-08-31
Budget End
2013-08-30
Support Year
2
Fiscal Year
2012
Total Cost
$116,040
Indirect Cost
$41,416
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Saslow, Laura R; Mason, Ashley E; Kim, Sarah et al. (2017) An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial. J Med Internet Res 19:e36
Moniz, Michelle H; Spector-Bagdady, Kayte; Heisler, Michele et al. (2017) Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice. Obstet Gynecol 130:783-787
Lager, Corey J; Esfandiari, Nazanene H; Subauste, Angela R et al. (2017) Roux-En-Y Gastric Bypass Vs. Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss. Obes Surg 27:154-161
Janz, Nancy K; Li, Yun; Zikmund-Fisher, Brian J et al. (2017) The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence. Breast Cancer Res Treat 161:525-535
Moniz, Michelle; Chang, Tammy; Heisler, Michele et al. (2017) Immediate postpartum long-acting reversible contraception: the time is now. Contraception 95:335-338
Birken, Sarah A; Powell, Byron J; Presseau, Justin et al. (2017) Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review. Implement Sci 12:2
Skolarus, Lesli E; Piette, John D; Pfeiffer, Paul N et al. (2017) Interactive Voice Response-An Innovative Approach to Post-Stroke Depression Self-Management Support. Transl Stroke Res 8:77-82
Isaman, Deanna J M; Rothberg, Amy E; Herman, William H (2017) The Effect of Attrition on Reported Diabetes Remission Rates Following Roux-en-Y Gastric Bypass: a Sensitivity Analysis. Obes Surg :
Wang, Sophia Y; Andrews, Chris A; Gardner, Thomas W et al. (2017) Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network. JAMA Ophthalmol 135:432-438
Janevic, Mary R; McLaughlin, Sara J; Heapy, Alicia A et al. (2017) Racial and Socioeconomic Disparities in Disabling Chronic Pain: Findings From the Health and Retirement Study. J Pain 18:1459-1467

Showing the most recent 10 out of 476 publications